Waters Corporation $WAT Shares Sold by Mountain Pacific Investment Advisers LLC

Key Points

• Mountain Pacific Investment Advisers LLC reduced its stake in Waters Corporation by 12.7%, selling 1,290 shares and now owns 8,891 shares valued at approximately $3.1 million.
• Waters Corporation reported a Q2 earnings per share (EPS) of $2.95, exceeding analysts' expectations, and projected Q3 2025 EPS guidance between 3.150 and 3.250.
• The company has a market capitalization of $19.03 billion and has seen a 1-year price range between $275.05 and $423.56.

Mountain Pacific Investment Advisers LLC cut its holdings in Waters Corporation (NYSE:WAT - Free Report) by 12.7% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 8,891 shares of the medical instruments supplier's stock after selling 1,290 shares during the period. Mountain Pacific Investment Advisers LLC's holdings in Waters were worth $3,103,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of WAT. UMB Bank n.a. grew its position in Waters by 2.8% during the 2nd quarter. UMB Bank n.a. now owns 1,055 shares of the medical instruments supplier's stock worth $368,000 after purchasing an additional 29 shares in the last quarter. Integrated Wealth Concepts LLC raised its stake in shares of Waters by 2.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier's stock worth $386,000 after purchasing an additional 30 shares in the last quarter. FourThought Financial Partners LLC raised its position in Waters by 5.1% during the first quarter. FourThought Financial Partners LLC now owns 658 shares of the medical instruments supplier's stock valued at $243,000 after acquiring an additional 32 shares in the last quarter. Brown Advisory Inc. raised its holdings in shares of Waters by 0.8% during the 1st quarter. Brown Advisory Inc. now owns 5,498 shares of the medical instruments supplier's stock valued at $2,026,000 after purchasing an additional 42 shares in the last quarter. Finally, Horizon Investments LLC lifted its stake in shares of Waters by 5.2% in the 1st quarter. Horizon Investments LLC now owns 852 shares of the medical instruments supplier's stock valued at $314,000 after purchasing an additional 42 shares during the last quarter. Institutional investors and hedge funds own 94.01% of the company's stock.

Waters Price Performance

Shares of Waters stock opened at $319.80 on Thursday. The stock has a market capitalization of $19.03 billion, a price-to-earnings ratio of 28.84, a P/E/G ratio of 2.80 and a beta of 1.04. The firm's 50-day moving average price is $295.93 and its two-hundred day moving average price is $326.36. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. Waters Corporation has a 1-year low of $275.05 and a 1-year high of $423.56.

Waters (NYSE:WAT - Get Free Report) last announced its earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 EPS for the quarter, topping the consensus estimate of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The business had revenue of $771.33 million for the quarter, compared to the consensus estimate of $745.96 million. During the same period in the previous year, the business earned $2.63 EPS. Waters's revenue was up 8.8% compared to the same quarter last year. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. On average, equities analysts predict that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

WAT has been the topic of several analyst reports. Robert W. Baird lowered their target price on shares of Waters from $374.00 to $352.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 16th. UBS Group restated a "neutral" rating on shares of Waters in a research note on Tuesday, July 15th. Wall Street Zen downgraded Waters from a "buy" rating to a "hold" rating in a research report on Saturday, July 26th. Wells Fargo & Company cut their price objective on Waters from $330.00 to $315.00 and set an "equal weight" rating for the company in a research report on Tuesday, August 5th. Finally, Jefferies Financial Group set a $385.00 target price on Waters and gave the company a "buy" rating in a research note on Monday, August 4th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $380.43.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.